Grants and Contributions:

Latex agglutination tests for rapid, instrument-free COVID-19 diagnostics in saliva

955869

$100,000.00

Sep 1, 2020 - Nov 30, 2020

The team aims to develop latex agglutination tests (LATs) that will allow for the detection of SARS-CoV-2 virus (to assess infection) and host antibodies to SARS-CoV-2 (to assess immunity) in saliva samples. The LATs will be completed in a single step, the results will be readable by visual inspection, and the tests will be completed in less than 5 minutes. Assay reagents will be tuned and optimized for lyophilization and storage (in formulations including custom stabilization reagent mixtures), such that they can be incorporated into NRC saliva collection and inspection cartridges at low cost. When complete, the new systems have the potential to revolutionize current COVID-19 testing protocols, allowing rapid and reliable testing at home, in airports, at border crossings, in long-term care facilities, and beyond.

National Research Council Canada

In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.

Toronto, Ontario, CA M5G 1L5

172-2020-2021-Q2-955869

Grant

Grants and Contributions

108162330

Academia

The Governing Council of the University of Toronto

University–Rosedale

35110

Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives

Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.

541710